NETest Liquid Biopsy Is Diagnostic of Lung Neuroendocrine Tumors and Identifies Progressive Disease
Malczewska A, Oberg K, Bodei L, Aslanian H, Lewczuk A, Filosso PL, Wójcik-Giertuga M, Rydel M, Zielińska-Leś I, Walter A, Suarez A, Kolasińska-Ćwikła A, Roffinella M, Jamidar P, Ziora D, Czyżewski D, Kos-Kudła B, Ćwikła J. NETest Liquid Biopsy Is Diagnostic of Lung Neuroendocrine Tumors and Identifies Progressive Disease. Neuroendocrinology 2019, 108: 219-231. PMID: 30654372, PMCID: PMC7472425, DOI: 10.1159/000497037.Peer-Reviewed Original ResearchConceptsSmall cell lung cancerLarge cell neuroendocrine carcinomaSquamous cell carcinomaIdiopathic pulmonary fibrosisBronchopulmonary carcinoidsNETest levelsLung cancerAtypical carcinoidLiquid biopsyLung neuroendocrine tumorsRECIST 1.1Stable diseaseMetastatic diseaseProgressive diseaseStudy cohortClinical progressionPulmonary fibrosisCell carcinomaNeuroendocrine carcinomaNeuroendocrine tumorsLung neoplasiaHealthy controlsNeuroendocrine neoplasiaBlinded studyBlood samples